<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Nummular eczema
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Nummular eczema
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Nummular eczema
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Matthew J Zirwas, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Joseph Fowler, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Rosamaria Corona, MD, DSc
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            May 25, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H4813942">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nummular eczema, also called discoid eczema or nummular dermatitis, is a chronic, inflammatory skin disease characterized by multiple pruritic, coin-shaped, eczematous lesions involving the extremities and, less commonly, the trunk  (
         <a class="graphic graphic_picture graphicRef96165" href="/z/d/graphic/96165.html" rel="external">
          picture 1A
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]. Nummular eczema is regarded as a distinctive form of endogenous (idiopathic) eczema, although some experts suggest that it should be reclassified as a subtype of atopic dermatitis [
         <a href="#rid2">
          2
         </a>
         ]. The author applies the American Academy of Dermatology criteria for atopic dermatitis [
         <a href="#rid3">
          3
         </a>
         ] and, if met in a given patient, considers atopic dermatitis to be the underlying diagnosis that is presenting with nummular lesions. If the criteria are not met, the author considers it to be idiopathic nummular eczema.
        </p>
        <p>
         This topic will discuss the clinical features, diagnosis, and treatment of idiopathic nummular eczema. Atopic dermatitis, allergic contact dermatitis, and other types of eczematous dermatitis are discussed separately.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1729.html" rel="external">
          "Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1730.html" rel="external">
          "Treatment of atopic dermatitis (eczema)"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13655.html" rel="external">
          "Clinical features and diagnosis of allergic contact dermatitis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13661.html" rel="external">
          "Irritant contact dermatitis in adults"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/13670.html" rel="external">
          "Stasis dermatitis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/96466.html" rel="external">
          "Urticarial dermatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4813956">
         <span class="h1">
          EPIDEMIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nummular eczema affects men more frequently than women. Most patients are over the age of 50, although individuals of any age can be affected [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4813963">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathogenesis of idiopathic nummular eczema is incompletely understood. Numerous factors have been implicated as causal, including xerosis and decreased cutaneous lipid production,
         <em>
          Staphylococcus
         </em>
         <em>
          aureus
         </em>
         colonization, contact allergy to metals, alcohol consumption, nonceliac gluten sensitivity, and sensitization to environmental aeroallergens such as
         <em>
          Candida albicans
         </em>
         or house dust mites [
         <a href="#rid1">
          1,5-12
         </a>
         ]. Nummular eczema has been reported in patients treated with
         <a class="drug drug_general" data-topicid="8582" href="/z/d/drug information/8582.html" rel="external">
          isotretinoin
         </a>
         and in patients with hepatitis C infection treated with interferon-alpha-2b and
         <a class="drug drug_general" data-topicid="9860" href="/z/d/drug information/9860.html" rel="external">
          ribavirin
         </a>
         [
         <a href="#rid13">
          13-15
         </a>
         ]. In a study of 1662 patients undergoing breast reconstruction, approximately 3 percent developed nummular eczema in the area of reconstruction [
         <a href="#rid16">
          16
         </a>
         ]. In nearly two-thirds of cases, nummular eczema developed after the implantation of tissue expanders or silicone implants, suggesting that stretching or tension applied to the skin may be a trigger for this type of dermatitis. A report of nummular eczema developing after initiating the interleukin (IL) 23 inhibitor
         <a class="drug drug_general" data-topicid="114007" href="/z/d/drug information/114007.html" rel="external">
          guselkumab
         </a>
         for psoriasis treatment suggests that the balance of Th1 and Th2 cytokines may play a role in the pathogenesis of some cases [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H63757045">
         <span class="h1">
          PATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The pathologic features of nummular eczema are indistinguishable from other forms of eczema, showing primarily spongiosis, superficial perivascular lymphocytic infiltrates, with some eosinophils and occasional neutrophils and plasma cells  (
         <a class="graphic graphic_picture graphicRef97004" href="/z/d/graphic/97004.html" rel="external">
          picture 2
         </a>
         ) [
         <a href="#rid18">
          18
         </a>
         ]. Mild papillary edema and vascular dilation may be present.
        </p>
        <p class="headingAnchor" id="H4813971">
         <span class="h1">
          CLINICAL MANIFESTATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nummular eczema typically presents with highly pruritic, round, coin-shaped patches of eczematous dermatitis ranging in diameter from 1 to 10 cm  (
         <a class="graphic graphic_picture graphicRef96165 graphicRef96163 graphicRef96164" href="/z/d/graphic/96165.html" rel="external">
          picture 1A-C
         </a>
         ). In the acute phase, lesions are dull red, exudative, and crusted. Over time, they become drier and scalier, occasionally with central clearing leading to annular lesions.
        </p>
        <p>
         The legs and the upper extremities are the sites most frequently involved. Involvement of the trunk is less common, but when present, the lower trunk is more likely to be involved than the upper trunk. If the face or neck is involved, alternative diagnoses should be considered.
        </p>
        <p>
         Nummular eczema is a chronic and relapsing disease. Days to months after resolution, apparently dormant lesions may become active again or new lesions may occur in adjacent areas.
        </p>
        <p class="headingAnchor" id="H4813985">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of nummular eczema is usually clinical, based upon the typical finding of round, coin-shaped, and highly pruritic lesions in a patient with diffusely dry skin. Biopsy or laboratory tests are generally not necessary for diagnosis. However, a skin swab for bacterial culture may be performed in patients with exudative or crusted lesions, initiating appropriate antibacterial therapy based on the results of the culture. Patch testing may be helpful in patients with recalcitrant disease and/or a history suggesting allergic contact dermatitis [
         <a href="#rid8">
          8,19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16691.html" rel="external">
          "Patch testing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4813992">
         <span class="h2">
          Differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis of nummular eczema includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Atopic dermatitis
         </strong>
         – Nummular lesions may be an atypical clinical presentation of atopic dermatitis in both adults and children, and distinguishing idiopathic nummular eczema from atopic dermatitis with primarily nummular lesions requires application of validated diagnostic criteria. The author prefers to use the American Academy of Dermatology criteria for this purpose [
         <a href="#rid20">
          20,21
         </a>
         ]. For example, in one report, 13 percent of older, White patients with atopic dermatitis presented with primarily nummular lesions [
         <a href="#rid22">
          22
         </a>
         ]. A history of atopic disease, including reactions to aeroallergens, asthma, and atopic dermatitis in typical flexural locations, supports the diagnosis of atopic dermatitis. (See
         <a class="medical medical_review" href="/z/d/html/1729.html" rel="external">
          "Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Allergic contact dermatitis
         </strong>
         – Allergic contact dermatitis may rarely present with lesions indistinguishable from nummular eczema. Comprehensive patch testing to contact sensitizers based upon the patient's history of exposure can clarify the diagnosis. In a large population of patients referred for patch testing due to eczematous lesions with a nummular morphology, nearly 25 percent had a positive patch test to a potentially relevant allergen (primarily those in personal care products), although there was no follow-up data to confirm that these patients improved with allergen avoidance [
         <a href="#rid23">
          23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13655.html" rel="external">
          "Clinical features and diagnosis of allergic contact dermatitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16691.html" rel="external">
          "Patch testing"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Tinea corporis
         </strong>
         – Early lesions of tinea corporis may mimic nummular eczema  (
         <a class="graphic graphic_picture graphicRef53823 graphicRef53271" href="/z/d/graphic/53823.html" rel="external">
          picture 3A-B
         </a>
         ). A potassium hydroxide (KOH) preparation will show the segmented hyphae and arthrospores characteristic of all dermatophyte infections. (See
         <a class="medical medical_review" href="/z/d/html/4030.html" rel="external">
          "Dermatophyte (tinea) infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Stasis dermatitis
         </strong>
         – Early lesions of stasis dermatitis may present as erythematous, scaly, and itchy patches  (
         <a class="graphic graphic_picture graphicRef70596" href="/z/d/graphic/70596.html" rel="external">
          picture 4
         </a>
         ). A history of venous insufficiency and/or the presence of other signs of chronic venous insufficiency such as varicosities, pitting edema, and hyperpigmentation support the diagnosis of stasis dermatitis. (See
         <a class="medical medical_review" href="/z/d/html/13670.html" rel="external">
          "Stasis dermatitis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Psoriasis
         </strong>
         – Psoriatic lesions are usually dry, with more prominent scaling, and asymptomatic, although some patients may complain of pruritus. (See
         <a class="medical medical_review" href="/z/d/html/5664.html" rel="external">
          "Psoriasis: Epidemiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prodromal bullous pemphigoid
         </strong>
         – Bullous pemphigoid can present with nonspecific, pruritic, eczematous lesions for a prolonged period prior to the appearance of classic blisters. In one case report, lesions typical of nummular eczema developed into classic, immunopathologically confirmed bullous pemphigoid [
         <a href="#rid24">
          24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16176.html" rel="external">
          "Clinical features and diagnosis of bullous pemphigoid and mucous membrane pemphigoid"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4813999">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The management of nummular eczema involves general measures aimed at reducing skin dryness and exposure to irritants and treatment of skin inflammation.
        </p>
        <p class="headingAnchor" id="H63757414">
         <span class="h2">
          General measures
         </span>
         <span class="headingEndMark">
          —
         </span>
         General measures to reduce skin dryness and exposure to skin irritants may include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Limit bathing to once daily with lukewarm water using mild, nonsoap cleansers.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Apply a moisturizer at least once, preferably twice, daily and immediately after bathing. The author prefers cream preparations over lotions due to the increased lipid content of creams compared with lotions. In addition, evidence has shown that a cream containing a mixture of ceramides is more effective at reducing water loss through the skin than traditional moisturizers [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Use laundry detergents that are based primarily on nonionic surfactants (laundry detergents for sensitive skin), which have the lowest potential for skin irritancy, and/or double rinse the laundry to minimize residual laundry detergent in clothing [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consider obtaining a whole house humidifier or a room humidifier for the bedroom.
        </p>
        <p>
        </p>
        <p>
         Oral supplementation with L-histidine 2000 mg/day in patients with idiopathic nummular eczema has been shown to increase filaggrin levels in keratinocytes and improve xerosis [
         <a href="#rid27">
          27
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H63757426">
         <span class="h2">
          First-line therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         High- or ultra-high potency topical corticosteroids (groups 1 to 3  (
         <a class="graphic graphic_table graphicRef62402" href="/z/d/graphic/62402.html" rel="external">
          table 1
         </a>
         )) are first-line therapy for nummular eczema. Topical corticosteroids are applied once or twice daily for two to four weeks or until resolution of the lesions. The use of occlusive dressings may enhance the corticosteroid penetration into the skin and may lead to a more rapid response.
        </p>
        <p>
         For isolated recalcitrant lesions, intralesional
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          triamcinolone
         </a>
         may be a treatment option. The author injects 0.5 to 1 mL of 4 to 5 mg/mL triamcinolone per lesion. Patients should be warned about the possibility of temporary atrophy or dyspigmentation.
        </p>
        <p>
         The efficacy of topical corticosteroids for the treatment of nummular eczema has not been evaluated in randomized trials. Their use is based upon indirect evidence of efficacy in other eczematous skin diseases (eg, atopic dermatitis, allergic contact dermatitis) and clinical experience.
        </p>
        <p class="headingAnchor" id="H4814013">
         <span class="h2">
          Severe or refractory disease
         </span>
        </p>
        <p class="headingAnchor" id="H77414229">
         <span class="h3">
          Phototherapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with extensive disease that does not respond to topical corticosteroids may be treated with narrowband ultraviolet B (NBUVB) therapy. Typically, 10 to 30 treatments given two to three times per week are necessary before a response is noted. If a response is not noted after 30 treatments, the therapy is discontinued. In patients who respond, the author reduces the frequency once all lesions are cleared to once weekly for a month, then to every other week for two months, as needed and tolerated. (See
         <a class="medical medical_review" href="/z/d/html/13745.html" rel="external">
          "UVB phototherapy (broadband and narrowband)"
         </a>
         .)
        </p>
        <p>
         If NBUVB therapy is not available or not possible for logistic reasons, commercial tanning beds or natural sunlight during the summer may be alternative options. If natural sunlight is utilized, patients should be instructed to start by obtaining 10 minutes of direct, unprotected sunlight between 10 AM and 2 PM and increasing the duration by several minutes daily, up to a maximum of 30 minutes daily. Lightly pigmented patients and those with red or blond hair may need to start with 5 minutes and limit the exposure time to a maximum of 20 minutes. Unaffected areas of the skin should be covered to limit unnecessary solar exposure.
        </p>
        <p>
         If commercial tanning beds are the only option, the author suggests that the patient find a convenient, local tanning salon. Because there is great variability in the output of different beds and bulbs, there is no standard recommendation for a starting exposure time or progressive increases. If there is no improvement in one month of going three times a week, treatment should be discontinued. If there is improvement, treatment can be reduced to once weekly for a month and then to every other week as needed.
        </p>
        <p>
         For all patients undergoing phototherapy, the potential increased risk of skin cancer should be weighed against the benefits of avoiding the use of systemic immunosuppressants in the individual patient.
        </p>
        <p class="headingAnchor" id="H77414235">
         <span class="h3">
          Systemic therapies
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with recalcitrant disease for whom phototherapy is not feasible, treatment options include systemic immunosuppressants (eg, systemic corticosteroids,
         <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">
          methotrexate
         </a>
         ,
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         ) and biologic immunomodulators:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Systemic immunosuppressants
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Systemic corticosteroids
         </strong>
         – The author's preference is to use intramuscular
         <a class="drug drug_general" data-topicid="10015" href="/z/d/drug information/10015.html" rel="external">
          triamcinolone
         </a>
         at a dose of 40 mg given up to once every three months. For clinicians who prefer oral corticosteroids,
         <a class="drug drug_general" data-topicid="9809" href="/z/d/drug information/9809.html" rel="external">
          prednisone
         </a>
         can be initiated at 40 mg per day, with the dose reduced by 10 mg every five days and then discontinued.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Methotrexate
         </strong>
         –
         <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">
          Methotrexate
         </a>
         10 to 15 mg per week is an alternative therapy for patients in whom systemic corticosteroids are contraindicated or in whom the disease recurs shortly after corticosteroid discontinuation. The author initiates methotrexate therapy with 10 mg weekly for six weeks. If the response is inadequate and laboratory monitoring has not shown any abnormalities, the dose is increased to 15 mg weekly for another four to six weeks. Once an adequate response is achieved, the dose is maintained for three to six months, then tapered by 2.5 mg every three months, and then stopped. In case of relapse, the prior dose that was effective is resumed.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Cyclosporine
         </strong>
         –
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          Cyclosporine
         </a>
         3 to 5 mg/kg per day is an additional alternative to systemic corticosteroids. The author initiates cyclosporine at a dose of 4 mg/kg per day (based upon ideal body weight). This dose is maintained until the disease is controlled (typically in two to six weeks). The dose is then reduced by 100 mg/day every one to two months until discontinuation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Systemic corticosteroids,
         <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">
          methotrexate
         </a>
         , or
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         for the treatment of nummular eczema have not been evaluated in clinical trials. Their use is based upon evidence of efficacy in the treatment of other forms of severe dermatitis. The use of methotrexate for nummular eczema has been reported in two series of 25 and 28 pediatric patients [
         <a href="#rid28">
          28,29
         </a>
         ]. Complete clearance was observed in 16 and 10 children, respectively, after an average treatment time of 10.5 months.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Biologic immunomodulators
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Dupilumab
         </strong>
         –
         <a class="drug drug_general" data-topicid="112484" href="/z/d/drug information/112484.html" rel="external">
          Dupilumab
         </a>
         , an interleukin (IL) 4 and IL-13 inhibitor approved for the treatment of moderate to severe atopic dermatitis, has been reported as effective in several small series of patients with nummular eczema, although it was not clearly defined if the patients included in these reports met the American Academy of Dermatology criteria for atopic dermatitis or were better classified as having idiopathic nummular eczema [
         <a href="#rid30">
          30-32
         </a>
         ]. However, the author has used dupilumab in several patients with idiopathic nummular eczema refractory to multiple treatments (including systemic corticosteroids,
         <a class="drug drug_general" data-topicid="9630" href="/z/d/drug information/9630.html" rel="external">
          methotrexate
         </a>
         , and
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         ) with disappointing results.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         In patients with recalcitrant nummular lesions who meet the American Academy of Dermatology criteria for the diagnosis of atopic dermatitis,
         <a class="drug drug_general" data-topicid="112484" href="/z/d/drug information/112484.html" rel="external">
          dupilumab
         </a>
         may be the first-line systemic agent.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H66627254">
         <span class="h1">
          PROGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prognosis is excellent in the author's experience, with disease control achieved in nearly all patients who are treated with systemic therapies (see
         <a class="local">
          'Systemic therapies'
         </a>
         above). Eventual long-term remission that allows discontinuation of therapy occurs in most patients, although relapses are possible.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4814035">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definition
         </strong>
         – Nummular eczema, also called discoid eczema, is a chronic, inflammatory skin disease characterized by multiple coin-shaped, eczematous lesions  (
         <a class="graphic graphic_picture graphicRef96165" href="/z/d/graphic/96165.html" rel="external">
          picture 1A
         </a>
         ). It can be idiopathic or a manifestation of atopic dermatitis. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical presentation
         </strong>
         – Nummular eczema typically presents with highly pruritic, round, coin-shaped patches of eczematous dermatitis ranging in diameter from 1 to 10 cm  (
         <a class="graphic graphic_picture graphicRef96163 graphicRef96164" href="/z/d/graphic/96163.html" rel="external">
          picture 1B-C
         </a>
         ). The legs and the upper extremities are the sites most frequently involved. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – The diagnosis of nummular eczema is clinical. Patch testing may be helpful in patients with recalcitrant disease and/or a history suggesting allergic contact dermatitis. (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Treatment
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We suggest high- or ultra-high potency topical corticosteroids (groups 1 to 3  (
         <a class="graphic graphic_table graphicRef62402" href="/z/d/graphic/62402.html" rel="external">
          table 1
         </a>
         )) as the first-line therapy for nummular eczema (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). Topical corticosteroids are applied twice daily for two to four weeks or until resolution of the lesions. (See
         <a class="local">
          'First-line therapy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with extensive or recalcitrant disease that does not respond to topical corticosteroids, narrowband ultraviolet B (NBUVB) phototherapy, systemic immunosuppressants, and
         <a class="drug drug_general" data-topicid="112484" href="/z/d/drug information/112484.html" rel="external">
          dupilumab
         </a>
         are alternative treatments. (See
         <a class="local">
          'Severe or refractory disease'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – Disease control and eventual cessation of the need for therapy are expected in most patients but may take several years to achieve. Relapses may occur. (See
         <a class="local">
          'Prognosis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Jiamton S, Tangjaturonrusamee C, Kulthanan K. Clinical features and aggravating factors in nummular eczema in Thais. Asian Pac J Allergy Immunol 2013; 31:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Butler DC, Simpson E, Guttman-Yassky E, et al. The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement. J Dermatolog Treat 2022; 33:2397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eichenfield LF, Tom WL, Chamlin SL, et al. Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis. J Am Acad Dermatol 2014; 70:338.
          </a>
         </li>
         <li class="breakAll">
          Susan Burgin. Nummular eczema, lichen simplex chronicus, and prurigo nodularis. In: Fitzpatrick's Dermatology in General Medicine, 8th ed, Goldsmith LA, Katz SI, Gilchrest BA, et al (Eds), McGraw-Hill, 2012. Vol 1, p.182.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim WJ, Ko HC, Kim MB, et al. Features of Staphylococcus aureus colonization in patients with nummular eczema. Br J Dermatol 2013; 168:658.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonamonte D, Foti C, Vestita M, et al. Nummular eczema and contact allergy: a retrospective study. Dermatitis 2012; 23:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krupa Shankar DS, Shrestha S. Relevance of patch testing in patients with nummular dermatitis. Indian J Dermatol Venereol Leprol 2005; 71:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khurana S, Jain VK, Aggarwal K, Gupta S. Patch testing in discoid eczema. J Dermatol 2002; 29:763.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schena D, Papagrigoraki A, Girolomoni G. Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema. Dermatol Ther 2008; 21 Suppl 2:S35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aoyama H, Tanaka M, Hara M, et al. Nummular eczema: An addition of senile xerosis and unique cutaneous reactivities to environmental aeroallergens. Dermatology 1999; 199:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jain NP, Shao K, Stewart C, Grant-Kels JM. The effects of alcohol and illicit drug use on the skin. Clin Dermatol 2021; 39:772.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freire de Carvalho J, Pithon Pereira C, Betania Pereira Torales M. Nummular Eczema Successfully Treated with a Gluten-free Diet: First Description. Isr Med Assoc J 2021; 23:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bettoli V, Tosti A, Varotti C. Nummular eczema during isotretinoin treatment. J Am Acad Dermatol 1987; 16:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shen Y, Pielop J, Hsu S. Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection. Arch Dermatol 2005; 141:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore MM, Elpern DJ, Carter DJ. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004; 140:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iwahira Y, Nagasao T, Shimizu Y, et al. Nummular Eczema of Breast: A Potential Dermatologic Complication after Mastectomy and Subsequent Breast Reconstruction. Plast Surg Int 2015; 2015:209458.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Truong A, Le S, Kiuru M, Maverakis E. Nummular dermatitis on guselkumab for palmoplantar psoriasis. Dermatol Ther 2019; 32:e12954.
          </a>
         </li>
         <li class="breakAll">
          Wu H, Branding-Bennett HA, Harrist TJ. Noninfectious vesicobullous and vesicopustular diseases. In: Lever's Histopathology of the Skin, 10th ed, Elder DE (Ed), 2008.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fleming C, Parry E, Forsyth A, Kemmett D. Patch testing in discoid eczema. Contact Dermatitis 1997; 36:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kulthanan K, Samutrapong P, Jiamton S, Tuchinda P. Adult-onset atopic dermatitis: a cross-sectional study of natural history and clinical manifestation. Asian Pac J Allergy Immunol 2007; 25:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Julián-Gónzalez RE, Orozco-Covarrubias L, Durán-McKinster C, et al. Less common clinical manifestations of atopic dermatitis: prevalence by age. Pediatr Dermatol 2012; 29:580.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chello C, Carnicelli G, Sernicola A, et al. Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature. Int J Dermatol 2020; 59:716.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Silverberg JI, Hou A, Warshaw EM, et al. Prevalence and trend of allergen sensitization in patients with nummular (discoid) eczema referred for patch testing: North American Contact Dermatitis Group data, 2001-2016. Contact Dermatitis 2021; 85:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mori T, Yamamoto T. Bullous pemphigoid developed on nummular eczema lesions. J Dermatol 2019; 46:e426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Danby SG, Andrew PV, Kay LJ, et al. Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema-prone skin. Br J Dermatol 2022; 186:875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coope-Epstein J, Zirwas MJ, Calderon A. Evaluation of the Relative Mildness of Commercial Sensitive Skin and Baby Laundry Detergents. Skinmed 2020; 18:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tan SP, Brown SB, Griffiths CE, et al. Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis. Clin Cosmet Investig Dermatol 2017; 10:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roberts H, Orchard D. Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children. Australas J Dermatol 2010; 51:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knöpfel N, Noguera-Morel L, Hernández-Martín A, Torrelo A. Methotrexate for severe nummular eczema in children: Efficacy and tolerability in a retrospective study of 28 patients. Pediatr Dermatol 2018; 35:611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Choi S, Zhu GA, Lewis MA, et al. Dupilumab treatment of nummular dermatitis: A retrospective cohort study. J Am Acad Dermatol 2020; 82:1252.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Patruno C, Stingeni L, Hansel K, et al. Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults. Dermatol Ther 2020; 33:e13290.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tavecchio S, Angileri L, Pozzo Giuffrida F, et al. Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients. J Clin Med 2020; 9.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 13666 Version 7.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23517392" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Clinical features and aggravating factors in nummular eczema in Thais.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34365875" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : The atopic dermatitis spectrum disorder. Recognizing the clinical heterogeneity in patients with atopic related skin conditions in order to improve therapeutic decision-making and outcomes: an expert panel consensus statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24290431" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24290431" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22630164" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Features of Staphylococcus aureus colonization in patients with nummular eczema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22828253" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Nummular eczema and contact allergy: a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16394482" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Relevance of patch testing in patients with nummular dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12532040" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Patch testing in discoid eczema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18837732" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10559579" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Nummular eczema: An addition of senile xerosis and unique cutaneous reactivities to environmental aeroallergens.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34785005" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The effects of alcohol and illicit drug use on the skin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34024054" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Nummular Eczema Successfully Treated with a Gluten-free Diet: First Description.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2950149" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Nummular eczema during isotretinoin treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15655158" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14967798" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26380109" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Nummular Eczema of Breast: A Potential Dermatologic Complication after Mastectomy and Subsequent Breast Reconstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31070862" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Nummular dermatitis on guselkumab for palmoplantar psoriasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31070862" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Nummular dermatitis on guselkumab for palmoplantar psoriasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9197962" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Patch testing in discoid eczema.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18402293" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Adult-onset atopic dermatitis: a cross-sectional study of natural history and clinical manifestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22469300" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Less common clinical manifestations of atopic dermatitis: prevalence by age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32311089" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Atopic dermatitis in the elderly Caucasian population: diagnostic clinical criteria and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33634511" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Prevalence and trend of allergen sensitization in patients with nummular (discoid) eczema referred for patch testing: North American Contact Dermatitis Group data, 2001-2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31282017" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Bullous pemphigoid developed on nummular eczema lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34921679" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema-prone skin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32167450" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Evaluation of the Relative Mildness of Commercial Sensitive Skin and Baby Laundry Detergents.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29042806" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Feeding filaggrin: effects of l-histidine supplementation in atopic dermatitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20546220" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: a case series of 25 children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29943852" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Methotrexate for severe nummular eczema in children: Efficacy and tolerability in a retrospective study of 28 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31923445" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Dupilumab treatment of nummular dermatitis: A retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32125741" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32824992" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Efficacy of Dupilumab on Different Phenotypes of Atopic Dermatitis: One-Year Experience of 221 Patients.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
